European Journal of Medicinal Chemistry p. 149 - 158 (1993)
Update date:2022-07-29
Topics:
Tsitsa
Antoniadou-Vyza
Hamodrakas
Eliopoulos
Tsantili-Kakoulidou
Lada-Hytiroglou
Roussakis
Chinou
Hempel
Camerman
Ottensmeyer
Vanden Berghe
A number of adamantyl-group-bearing diamino-s-triazines were synthesized as potential dihydrofolate reductase (DHFR) inhibitors and their pharmacological properties were tested. The crystal structures of certain compounds were determined by X-ray crystallography. With the aid of computer graphics, model structures of the L1210 mouse DHFR-ligand ternary complex were constructed. The binding affinities of the compounds to DHFR were determined experimentally. Compounds mono-substituted at the nitrogen of the amine group appear to be slightly better inhibitors. Weak activity was also enhanced by the presence of a methylene bridge between the adamantyl group and the s-triazine ring. The majority of the compounds was shown to have weak activity against P388 and KB cell lines in vitro; some compounds showed weak anti-bacterial activity and no anti-viral activity was detected.
View MoreContact:+86 21 5017 5386
Address:No 999,Jiangyue Rd, Minhang Dist ,201114,Shanghai ,China
Hebei Think-Do Environment Co., Ltd
website:http://www.thinkdo-environment.com
Contact:0311-86510809
Address:No 6, Shilian Middle Street, Circular Chemical Industry Park
website:http://www.sjc.com.tw
Contact:(886) 2-2396-6223
Address:14Fl., No. 99. Sec. 2, Jen Ai Road
Contact:86-170-000000
Address:No.168 Road,han city, China
Chengdu D-Innovation Pharmaceutical Co., Ltd
Contact:86-28-85105536
Address:1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone
Doi:10.1002/anie.202010606
(2021)Doi:10.1002/1521-3773(20020315)41:6<1062::AID-ANIE1062>3.0.CO;2-8
(2002)Doi:10.1021/om500452c
(2014)Doi:10.1023/A:1013931500566
()Doi:10.1002/1522-2675(200201)85:1<288::AID-HLCA288>3.0.CO;2-I
(2002)Doi:10.1055/s-2002-19749
(2002)